Related Experiment Video

Updated: Aug 10, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

[Meningitis caused by Haemophilus influenzae type B, resistant to ampicillin and chloramphenicol]

F de Juan Martín, M L Aisa Iriarte, J Boné Calvo

    Anales Espanoles De Pediatria
    |August 1, 1984
    PubMed

    Insights

    Multidrug-resistant Haemophilus influenzae type b meningitis poses treatment challenges. Third-generation cephalosporins effectively treated ampicillin and chloramphenicol-resistant cases, offering a viable therapeutic option.

    Area of Science:

    • Infectious Diseases
    • Microbiology
    • Pharmacology

    Background:

    • Haemophilus influenzae type b (Hib) meningitis is a serious infection.
    • Emergence of antibiotic resistance in Hib strains complicates treatment.
    • Ampicillin and chloramphenicol resistance present significant therapeutic hurdles.

    Observation:

    • Four cases of Hib meningitis were analyzed, with three exhibiting resistance to both ampicillin and chloramphenicol.
    • One case showed ampicillin resistance and chloramphenicol allergy.
    • Patients were treated with various cephalosporin generations (cefacetrile, cefamandole, cefotaxime, moxalactam) based on availability.

    Findings:

    • All patients demonstrated excellent clinical improvement.
    • Third-generation cephalosporins (cefotaxime, moxalactam) were particularly effective.
    • Successful treatment outcomes were achieved despite multidrug resistance.

    Implications:

    • Third-generation cephalosporins are a valuable therapeutic option for ampicillin and chloramphenicol-resistant Hib meningitis.
    • This finding is crucial for guiding treatment strategies in areas with high rates of antibiotic resistance.
    • Further research into cephalosporin efficacy against resistant bacterial meningitis is warranted.

    More Related Videos

    Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells10:12

    Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells

    Published on: July 14, 2020

    Assessing Respiratory Immune Responses to Haemophilus Influenzae06:32

    Assessing Respiratory Immune Responses to Haemophilus Influenzae

    Published on: June 29, 2021

    Related Concept Videos

    Bacterial Meningitis01:24

    Bacterial Meningitis

    Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
    Viral Meningitis01:18

    Viral Meningitis

    Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Bacterial Meningitis I: Introduction01:22

    Bacterial Meningitis I: Introduction

    Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
    Bacterial Meningitis II: Pathophysiology01:26

    Bacterial Meningitis II: Pathophysiology

    Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...